Review paper highlights substandard COVID-19 research in both peer-review journals and pre-review websites
14 October 2020. Related: COVID-19: other news, COVID-19.
2020
Oxford COVID vaccine enrolling HIV positive people at two London sites
11 October 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
HTB: no. 10 – HIV and COVID-19: issue 7 (28 August 2020)
28 August 2020. Related: Editorial.
23rd International AIDS Conference (AIDS 2020): second reports
28 August 2020. Related: Conference reports.
Capsid inhibitor lenacapavir (GS-6207) allows for 6-monthly dosing
28 August 2020. Related: Conference reports, Antiretrovirals.
Weight gain with integrase inhibitors and TAF: three reports from AIDS 2020
28 August 2020. Related: Conference reports, Side effects.
Dolutegravir non-inferior to efavirenz at week 96 in the NAMSAL study but associated with substantial weight gain
28 August 2020. Related: Conference reports, Treatment strategies.
Switching from efavirenz- to dolutegravir-based ART second-line achieved good rates of suppression: first results from the VISEND study
28 August 2020. Related: Conference reports, Treatment strategies.
Paediatric dolutegravir dosing at AIDS 2020
28 August 2020. Related: Conference reports, Paediatric care.
COVID-19 outcomes in HIV positive people in two large US cohorts
28 August 2020. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
AIDS 2020: virtual content now available free and on-demand
28 August 2020. Related: Conference reports, Other news.
Pathways to an HIV cure: online presentations
28 August 2020. Related: Conference reports, Cure-related research.
US FDA approves dolutegravir/lamivudine (Dovato) as switch option
28 August 2020. Related: Antiretrovirals.
EMA extends indication for darunavir/r to include adolescents >12 years
28 August 2020. Related: Antiretrovirals.
ViiV resubmits cabotegravir plus rilpivirine long-acting injections (Cabenuva, Vocabria) to FDA for approval
28 August 2020. Related: Antiretrovirals.
EMA supports use of dapivirine vaginal ring to prevent HIV in high-incidence countries
28 August 2020. Related: HIV prevention and transmission.
HIV organisations challenge government proposal to abolish Public Health England
28 August 2020. Related: Other news.
Modern ART – community video
28 August 2020. Related: On the web.
AVAC web interviews about new treatments to prevent HIV
28 August 2020. Related: On the web.
HIV associated with worse outcomes from COVID-19 in UK ISARIC and OpenSAFELY databases
28 August 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
European and UK doctors review latest studies on HIV and COVID-19 coinfection
28 August 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Tocilizumab associated with better outcomes from COVID-19 in US study
28 August 2020. Related: COVID-19: investigational drugs, COVID-19.
Famotidine associated with better outcomes from COVID-19
28 August 2020. Related: COVID-19: investigational drugs, COVID-19.
INSIGHT network to study monoclonal antibodies for COVID-19 including LY-CoV555
28 August 2020. Related: COVID-19: investigational drugs, COVID-19.
US activists ensure people living with HIV can enrol in COVID-19 vaccine studies
28 August 2020. Related: COVID-19: vaccine research, COVID-19.
HIV organisations oppose active-challenge COVID-19 vaccine studies
28 August 2020. Related: COVID-19: vaccine research, COVID-19.
AVAC webinar with Barney Graham: COVID-19 vaccine targets, timelines, efficacy and ethical issues
28 August 2020. Related: COVID-19: vaccine research, COVID-19.
Equitable access to vaccines against COVID-19
28 August 2020. Related: COVID-19: vaccine research, COVID-19.
HTB no 10 – plus: HIV and COVID-19 bulletin no 7 (28 August 2020)
28 August 2020. Related: PDFs.
HTB: no. 9 – HIV and COVID-19: issue 6 (22 July 2020)
22 July 2020. Related: Editorial.
IAS COVID-19 Conference: introduction
22 July 2020. Related: Conference reports.
Conference opening and making sense of the science
22 July 2020. Related: Conference reports, COVID-19.
HepC drugs for COVID-19: sofosbuvir/daclatasvir show faster recovery and reduced mortality
22 July 2020. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
Predictors of response to remdesivir in GS-5773 COVID-19 study
22 July 2020. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
AIDS 2020 online: introduction
22 July 2020. Related: Conference reports.
AIDS 2020: Navigating the website
22 July 2020. Related: Conference reports.
Neural tube defects in two of 1000 conception exposures with dolutegravir: reassuring update from Tsepamo study
22 July 2020. Related: Conference reports, Pregnancy.
Dolutegravir associated with weight gain in African ART programmes: findings from AFRICOS
22 July 2020. Related: Conference reports, Side effects.
ADVANCE 96-week results: dolutegravir weight gain continues, especially in women and when used with TAF – no evidence of a plateau
22 July 2020. Related: Conference reports, Antiretrovirals.
Obesity linked to dolutegravir, especially with TAF, could increase risk of adverse pregnancy outcomes
22 July 2020. Related: Conference reports, Women's health, Pregnancy, Side effects.
Pregnancy meta-analysis: dolutegravir- versus efavirenz-based ART
22 July 2020. Related: Conference reports, Pregnancy.
Long-acting cabotegravir injections are effective as HIV PrEP in gay men and transgender women: results from HPTN 083
22 July 2020. Related: Conference reports, HIV prevention and transmission.
Case report of short-term HIV remission from adding oral nicotinamide to intensified ART
22 July 2020. Related: Conference reports, Cure-related research.
New HIV remission case report at AIDS 2020: full report
22 July 2020. Related: Conference reports, Cure-related research.
FDA approves fostemsavir (Rukobia) for multidrug resistant HIV in the US
22 July 2020. Related: Antiretrovirals.
UK government cuts HIV PrEP budget in England by a third
22 July 2020. Related: HIV prevention and transmission.
BHIVA virtual conference: Best of CROI and COVID-19 update
22 July 2020. Related: On the web.
Access and procurement to ARVs in the Russian federation
22 July 2020. Related: On the web.
Pneumocystis Jirovecii Pneumonia (PJP) mistaken for COVID-19 in late stage undiagnosed: urgency of including HIV testing on admission
22 July 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
NYC cohort reports similar outcomes from COVID-19 in HIV positive vs HIV negative adults
22 July 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Spanish study reports associations between COVID-19 and HIV treatment including NRTIs
22 July 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
UK study reports inhaled interferon-Beta reduces time to recovery from COVID-19
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Review of COVID-19 in people with immune suppression
22 July 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
EMA grants conditional approval for remdesivir in the EU to treat COVID-19
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Drug price announced for remdesivir – as US buys up world stock
22 July 2020. Related: COVID-19: treatment access, COVID-19.
RECOVERY study reports that lopinavir/r fails to show benefit against COVID-19
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Hydroxychloroquine and lopinavir/r arms stopped in the WHO SOLIDARITY study
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Individualising management of COVID-19 based on real-time inflammatory responses
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Further positive reports from tocilizumab to treat COVID-19
22 July 2020. Related: COVID-19: investigational drugs, COVID-19.
Higher mortality from COVID-19 in London study in Asian or Black compared to white participants
22 July 2020. Related: COVID-19: pathogenesis, COVID-19.
UK study reports antibody responses linked to more severe COVID-19 in higher risk populations
22 July 2020. Related: COVID-19: pathogenesis, COVID-19.
Leading SARS-CoV-2 antibody tests meet specificity but fail current sensitivity guidelines
22 July 2020. Related: COVID-19: diagnostics, COVID-19.
Infectious SARS-CoV-2 in air and on surfaces in London hospitals
22 July 2020. Related: COVID-19: transmission & prevention, COVID-19.
US prisoners have higher mortality rates from COVID-19
22 July 2020. Related: COVID-19: transmission & prevention, COVID-19.
US SARS-CoV-2 epidemic could see 100,000 cases per day: NIAID head Anthony Fauci to Senate hearing
22 July 2020. Related: COVID-19: transmission & prevention, COVID-19.